Skip to main content
OpenTrials
Completed

NCT Number: NCT00799734

Chinese Medicine Therapy on Menopausal Symptoms

The objective of this study is to evaluate whether a Chinese medicine formula (Erxian Decoction,EXD) is effective in alleviating menopausal symptoms, improving sex hormone profile and bone turn-over.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Department of Obstetrics and Gynecology, the University of Hong Kong, Hong Kong, Hksar, China

Loading trial locations.

About this study

This is a double-blind randomized placebo-controlled clinical trial to evaluate whether a Chinese medicine formula (Erxian Decoction) is effective in alleviating menopausal symptoms. This study will be conducted in Queen Mary Hospital and Chinese Medicine Clinic cum Training and Research Centers of the University of Hong Kong (Sassoon Road and Central). Women will be recruited from the general population by advertisements and promotion through media coverage.108 Chinese women with menopausal symptoms will be recruited and randomized into two groups.One is treatment group with 12 weeks of Erxian Decoction (well-controlled granules), the other is controlled group with 12 weeks of placebo. The treatment outcome measures include: 1) the severity of menopausal symptoms: self-recording of daily frequency of vasomotor symptoms (hot flushes plus night sweats),the Menopause-Specific Quality of Life (MENQOL) Questionnaire and the Menopause Rating Scale(MRS). 2)biochemical indices:serum follicle-stimulating hormone(FSH),luteinizing hormone(LH),estradiol, progesterone levels. 3)safety indices: blood count,liver and renal function tests. All measures are conducted at baseline and endpoint except the self-recoding of vasomotor symptoms and MENQOL Questionnaire, MRS. We expect this research will provide an effective and low-cost therapy for menopausal symptoms.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chinese women aged 45 to 55 years old
  • having irregular menstrual cycles (≥3 months) indicating perimenopausal status or with cessation of menstrual period for at least three months within the previous 12 months
  • Total scores of Menopause Rating Scale≥28 indicating the menopausal symptoms are moderate or severe
  • Not having used HRT or Chinese Medicine for at least 3 months prior to entry into the study
  • Willing to give informed ,written consent to participate in the clinical study

Exclusion criteria

  • Taking hormones or medications, which could affect the vasomotoric symptoms
  • Having chronic illness, such as gastrointestinal, renal or liver disease, diabetes mellitus requiring treatment, uncontrolled hypertension
  • Having serious diseases, such as cancer, autoimmune system diseases, thrombosis and thrombophlebitis
  • Consuming alcohol, or taking psychiatric or psychotherapeutic drugs

Treatment and study plan

EXD

Drug

Interventions: Intake of prepacked Chinese herbal medicine therapy (EXD), one sachet of granules (15g extracted granules) twice a day and placebo therapy of 15g granules with similar colour and taste.

Other names: Er-xian Decoction (Prod. Code:3PP3082-3083)

Primary outcomes

  1. The severity of menopausal symptoms: self-recording of daily frequency of vasomotor symptoms (hot flushes plus night sweats),the Menopause-Specific Quality of Life (MENQOL) Questionnaire and the Menopause Rating Scale(MRS).

    Time frame: every four weeks

Secondary outcomes

  1. bone markers (N-MID osteocalcin and serum crosslaps)

    Time frame: 12 weeks

  2. Serum follicle-stimulating hormone (FSH), luteinizing hormone(LH), estradiol, progesterone levels

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Official study title

A Double-blind Randomized Placebo-controlled Clinical Trial on the Effects of Chinese Medicine Formula (Erxian Decoction) on Menopausal Symptoms

Important dates

Study start
2009
Primary completion
2010
Study completion
2011
First posted
Dec 1, 2008
Registry last updated
Jul 26, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.